/VEXTF
Vext Science, Inc.
VEXTF • OTCVEXTF • OTC • Healthcare
$0.18+4.11%+0.01
$0.18+4.11%(+0.01)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
70Bullish
Risk
90Low Risk
Momentum
44Neutral
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
24.9%▼9.6pp
Revenue after COGS
Operating
-31.1%▼25.9pp
After operating expenses
Net
-62.3%▼75.0pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
-1.2
Price vs earnings
EV/EBITDA
-30.8
Enterprise value
FCF Yield
6.7%
Cash generation
Earnings Yield
-82.3%
Inverse of P/E
Capital Efficiency
-17
GoAI Quality ScorePoor
ROEReturn on Equity
-29.6%Weak
ROAReturn on Assets
-16.4%Weak
ROICReturn on Invested Capital
-9.0%Weak
Financial Health
Current RatioAdequate
1.48
Short-term solvency (>1.5)
Net Debt / EBITDANet Cash
-17.27x
Debt repayment capacity (<3x)
Income QualityWeak
-0.15
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $36.00M | $34.81M | $35.41M | $37.24M | $25.19M |
| Gross Profit | $8.98M | $12.04M | $23.10M | $18.69M | $11.20M |
| Gross Margin | 24.9% | 34.6% | 65.2% | 50.2% | 44.5% |
| Operating Income | -$11.18M | -$1.80M | $8.93M | $9.49M | $3.22M |
| Net Income | -$22.44M | $4.40M | $10.92M | $4.99M | $2.13M |
| Net Margin | -62.3% | 12.6% | 30.8% | 13.4% | 8.4% |
| EPS | -$0.09 | $0.03 | $0.08 | $0.04 | $0.02 |
Earnings History & Surprises
BEAT RATE
36%
Last 11 quarters
AVG SURPRISE
-21.5%
EPS vs Estimate
BEATS / MISSES
4/5
2 met exactly
LATEST EPS
$-0.01
Q4 '25
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q4 '25
-51.6%
$-0.01 vs $-0.01
Q3 '25
-70.6%
$-0.01 vs $-0.00
Q2 '25
$-0.01 vs $-0.01
Q4 '24
No data
Q4 '24
$-0.01 vs $-0.01
Q3 '24
-78.9%
$-0.02 vs $-0.01
Q2 '24
-27.6%
$-0.03 vs $-0.02
Q4 '23
No data
Q4 '23
-231.6%
$-0.01 vs $-0.00
Q3 '23
+148.5%
$0.00 vs $-0.01
Q1 '23
No data
Q4 '22
No data
No investor questions available.
Latest News
No news available